Back

Association of altered lipid profile with disease activity, duration, and glucocorticoid treatment in patients with idiopathic inflammatory myopathies

15 April 2021 (08:00 - 19:20)
Organised by:
Congress Presentation Part of: ePosters Lipids EAPC Premium Access ESC Preventive Cardiology 2021

About the speaker

Photo
Doctor Sabina Oreska

Institute of Rheumatology, Nove Mesto (Czechia)

334 More presentations in this session

Presentation thumbnail
A diet-related microsimulation modelling approach in the context of cardiovascular disease prevention: the ATTICA and GREECS epidemiological studies.
Professor D. Panagiotakos (Athens, GR)
Abstract Slides
Presentation thumbnail
s-VCAM-1 is an independent predictor of all-cause mortality in patients with dilated cardiomyopathy and hypokinetic non-dilated cardiomyopathy
Doctor K. Lehnert (Greifswald, DE)
Abstract Slides
Presentation thumbnail
Age-standardized prevalence of social determinants of health and associated race-ethnic disparities in stroke survivors
Doctor T. Parekh (Newark, US)
Abstract Slides
Presentation thumbnail
Impact of Proteinuria and Low eGFR on Lifetime Risk of Cardiovascular Disease Death: A Pooled Analysis of Data From the Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Study
Ms Y. Imai (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Risk of cerebrovascular accidents according to weather and pollution features
Associate Professor G. Biondi-Zoccai (Latina, IT)
Abstract Slides

Access the full session

Session thumbnail
ePosters

The Event

Event poster

ESC Preventive Cardiology 2021

15 April 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Relationship between blood lipid panel with body mass, smoke exposure, dyspnea, physical activity, and quality of life in patients with dyslipidemia
26 April 2024
thumbnail
Congress Presentation
Takotsubo's cardiomyopathy in patients with pre-existing autoimmune diseases : a national inpatient sample analysis
26 August 2022
thumbnail
Congress Presentation
Two week interruption of statin therapy results in an exaggerated inflammatory phenotype in young myocardial infarction patients without standard modifiable risk factors
28 August 2022
thumbnail
Congress Presentation
Autoantibodies directed against apolipoprotein-a-1 as a potential contributor to non-alcoholic fatty liver disease
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources